Private Advisor Group’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Private Advisor Group's BMY Position: Q2 2026 in Review
Private Advisor Group reduced its Bristol-Myers Squibb (BMY) stake by 28% in Q2 2026, selling an estimated $4.26M and leaving 194,227 shares worth $11.2M. The position accounts for 0.05% of the portfolio, ranked #359.
Private Advisor Group first reported a position in BMY in Q4 2013 and has held it in 51 quarters since. The position peaked at $31.9M in Q3 2021. 2,519 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Private Advisor Group held 194,227 shares of Bristol-Myers Squibb worth $11.2M as of Q2 2026.
- Private Advisor Group sold 74,273 Bristol-Myers Squibb shares in Q2 2026, an estimated $4.26M.
- Bristol-Myers Squibb made up 0.05% of Private Advisor Group's portfolio in Q2 2026, its #359 holding.
- Private Advisor Group first reported a position in Bristol-Myers Squibb in Q4 2013 and has held it in 51 quarters since.
- Private Advisor Group's Bristol-Myers Squibb position peaked at $31.9M in Q3 2021.
- 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Private Advisor Group's 13F filing for Q2 2026, filed 27 Jul 2026.